COO
The Cooper Companies, Inc.
70.17
2 x 70.11
4 x 70.24
bid
ask
-
1.26
1.76%
3 @ 04:00 PM
71.25 +1.08 (1.53%)
Ytd -14.39%
1y -13.62%
69.34
day range
71.86
64.32
52 week range
84.44
Open 70.70 Prev Close 71.43 Low 69.34 High 71.86 Mkt Cap 13.69B
Vol 1.98M Avg Vol 2.07M EPS 2.01 P/E 34.91 Forward P/E 13.98
Beta 1.03 Short Ratio 2.77 Inst. Own 105.81% Dividend N/A Div Yield N/A
Ex Div Date 07-26 Earning 05-28 50-d Avg 77.90 200-d Avg 74.61 1yr Est 91.80
Earning
Date For Estimate Reported Surprise surprise %
2026-03-05 2026-01 1.03 1.1 0.07 6.80%
2025-12-04 2025-10 1.11 1.15 0.04 3.60%
2025-08-27 2025-07 1.07 1.1 0.03 2.80%
2025-05-29 2025-04 0.93 0.96 0.03 3.23%
2025-03-06 2025-01 0.92 0.92 N/A N/A
2024-12-05 2024-10 1 1.04 0.04 4.00%
Upgrade / Downgrade
Date Firm Action From To
2026-03-06 Citigroup Upgrade Neutral Neutral
2026-03-06 Barclays Upgrade Overweight Overweight
2026-03-06 Needham Upgrade Buy Buy
2026-02-03 Needham Upgrade Buy Buy
2026-01-26 Barclays Upgrade Overweight Overweight
2025-12-08 Citigroup Upgrade Neutral Neutral
Profile
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Insider Holder
Date Name Relation Quantity Description
2026-01-07 ANDREWS BRIAN G Chief Financial Officer 30.73K Conversion of Exercise of derivative security
2026-01-11 JAY COLLEEN E Director 36.59K Conversion of Exercise of derivative security
2025-03-31 KOZY WILLIAM A Director 31.15K Conversion of Exercise of derivative security
2025-03-31 MADDEN TERESA SMITH Director 12.36K Conversion of Exercise of derivative security
2026-01-07 MCBRIDE DANIEL G Chief Operating Officer 163.85K Conversion of Exercise of derivative security
2025-12-17 RIVAS MARIA Director 0.00 Purchase
Institution Ownership
Report Date Organization Position Value Percentage
2025-12-30 Vanguard Group Inc 23.55M 1.65B 12.07%
2025-12-30 Blackrock Inc. 16.49M 1.16B 8.45%
2025-12-30 Capital World Investors 10.21M 716.31M 5.23%
2025-12-30 T. Rowe Price Investment Management, Inc. 9.05M 634.84M 4.64%
2025-12-30 State Street Corporation 8.79M 617.06M 4.51%
2025-12-30 Kayne Anderson Rudnick Investment Management LLC 7.20M 505.15M 3.69%
Fund Ownership
Report Date Organization Position Value Percentage
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund 6.23M 436.81M 3.19%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard 500 Index Fund 5.01M 351.66M 2.57%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund 4.51M 316.57M 2.31%
2025-12-30 T. Rowe Price Mid-Cap Growth Fund, Inc. 4.27M 299.89M 2.19%
2025-12-30 NEW PERSPECTIVE FUND 3.61M 253.13M 1.85%
2025-12-30 T. Rowe Price Mid-Cap Value Fund, Inc. 3.18M 222.95M 1.63%
Dividend
Dividend Date
0.03 2023-07-27
0.03 2023-07-26
0.03 2023-01-20
0.03 2022-07-26
0.03 2022-01-20
0.03 2021-07-26
Split
Split Date
4 : 1 2024-02-20
2 : 1 2002-11-25
1 : 3 1995-09-22
110 : 100 1983-09-26